Mode
Text Size
Log in / Sign up

Coronavirus Disease 2019

Part of SARS-CoV-2 infection

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Coronavirus Disease 2019

7 trials tracked for Coronavirus Disease 2019.

7Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 5 Phase 1 1 Other / NA 1
  1. Phase 2 Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 Completed
  2. Phase 2 Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19 Completed
  3. Phase 2 Fostamatinib for Hospitalized Adults With COVID-19 Completed
  4. Phase 2 Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) Completed
  5. Phase 2 Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19 Completed
  6. Phase 1 A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 Completed
Show 1 more trials
  1. N/A Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19). Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.